media

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address

Registered & Corporate Office : 717/718, Maker Chambers V, , Nariman Point,
Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

Universal Capital Securities Pvt. Ltd.
C 101, 247 Park, LBS Road, Vikhroli West,
Mumbai,400083,Maharashtra
Tel: 022-28207203
Fax: 28207207

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal Ltd. - Analysts/Institutional Investor Meet/Con...

15-May-2024|12:33PM

Hikal Limited has informed the Exchange about Transcript of earnings call h

Hikal Ltd. - Announcement under Regulation 30 (LODR)-...

15-May-2024|12:23PM

Transcript of earnings call held on May 9, 2024 for quarter and financial y

Hikal Q4 net profit down 6.13% at Rs 33.86 cr

09-May-2024|8:00PM

The company reported standalone net profit of Rs 33.86 crore for the quarte

Hikal Ltd. - Announcement under Regulation 30 (LODR)-...

09-May-2024|7:29PM

Submission of audio recording of earnings conference call for the period en

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug49.90139.99
Aarti Drug494.104,542.51
Aarti Pharma579.455,251.32
Abbott India26,438.7556,180.50
Accent Micro301.85635.18
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
Tata Sm..100.191.44
Motilal..1.860.19
Motilal..0.020.12
Groww N..0.010.01
More

Board Meetings

DatePurpose
09/05/2024Audited Results & F..
08/02/2024Quarterly Results &..
02/11/2023Quarterly Results
08/08/2023Quarterly Results
29/05/2023Audited Results & F..
More